Sundrug Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Sundrug stock has a consensus rating of "Buy" and an average price target of ¥4,746. The average 1-year stock price forecast is 25.15% higher than the current stock price, while the lowest is ¥3,920 (+3.38%) and the highest is ¥5,600 (+47.68%).

Price Target: ¥4,746 (+25.15%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	¥3,920	¥4,746	¥5,000	¥5,600
Change	+3.38%	+25.15%	+31.86%	+47.68%

Analyst Ratings

The average analyst rating for Sundrug stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	2	2	2	2	2
Buy	2	2	2	2	2	2
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst SMBC Nikko No rating	SMBC Nikko	Hold Maintains ¥4,200	Hold	Maintains	¥4,200	+10.76%	Jun 3, 2026
Unknown Analyst UBS No rating	UBS	Hold Maintains ¥4,260 → ¥3,920	Hold	Maintains	¥4,260 → ¥3,920	+3.38%	May 27, 2026
Unknown Analyst Mizuho Securities No rating	Mizuho Securities	Buy Maintains ¥5,100	Buy	Maintains	¥5,100	+34.49%	May 22, 2026
Dairo Murata J.P. Morgan	J.P. Morgan	Hold Maintains ¥4,500 → ¥4,400	Hold	Maintains	¥4,500 → ¥4,400	+16.03%	Apr 13, 2026
Unknown Analyst Iwai Cosmo No rating	Iwai Cosmo	Buy Maintains ¥5,400	Buy	Maintains	¥5,400	+42.41%	Dec 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

900.19B

from 842.51B

6.85%

from 842.51B

Revenue Next Year

954.70B

from 900.19B

6.05%

from 900.19B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	648.73B	690.46B	751.78B	801.81B	842.51B	900.19B
Revenue Growth	2.27%	6.43%	8.88%	6.65%	5.08%	6.85%
Gross Profit	156.51B	171.95B	189.32B	204.09B	216.17B	232.41B
Gross Margin	24.12%	24.90%	25.18%	25.45%	25.66%	25.82%
Operating Income	34.05B	37.45B	41.00B	44.50B	46.83B	50.84B
Net Income	23.85B	25.70B	29.13B	30.75B	31.39B	33.76B
Dividend / Share	71.00	100.00	114.00	130.00	-	135.60
Free Cash Flow	10.19B	11.72B	-3.79B	689.13M	5.12B	13.85B
No. Analysts	-	-	-	-	-	7

Financial currency is JPY.

Revenue Forecast

Revenue	2027	2028	2029
High	921.0B
Avg	900.2B
Low	878.0B

Revenue Growth

Revenue Growth	2027	2028	2029
High	9.3%
Avg	6.8%
Low	4.2%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2028	2029
High	-
Avg	-
Low	-